Danaher Corp
DHR196.500USD
0.000
Market hours （ET）Quotes delayed by 15 min
140.62BMarket Cap
36.06P/E TTM
More Details of Danaher Corp Company
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company Info
Company codeDHR
Company nameDanaher Corp
IPO dateDec 10, 1969
Founded at1986
CEOMr. Rainer M. Blair
Number of employees61000
Security typeOrdinary Share
Fiscal year-endDec 10
Address2200 Pennsylvania Ave NW Ste 800W
CityWASHINGTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code20037-1701
Phone12028280850
Websitehttps://www.danaher.com/
Company codeDHR
IPO dateDec 10, 1969
Founded at1986
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
43.49M
--
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
34.93M
-0.58%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
84.94K
-0.46%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
74.02K
+418.18%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
38.24K
-1.01%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President, General Counsel
Senior Vice President, General Counsel
22.53K
+445.78%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-22.69%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
12.89K
-2.94%
Prof. Raymond C. Stevens, Ph.D.
Prof. Raymond C. Stevens, Ph.D.
Independent Director
Independent Director
6.38K
+1.54K%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
5.71K
+90.72%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
43.49M
--
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
34.93M
-0.58%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
84.94K
-0.46%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
74.02K
+418.18%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
38.24K
-1.01%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President, General Counsel
Senior Vice President, General Counsel
22.53K
+445.78%
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
All Other
11.14B
46.67%
United States
9.93B
41.58%
China
2.81B
11.75%
By Business
By Region
No Data
Shareholder
Update time: Fri, Apr 4
Update time: Fri, Apr 4
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.31%
Rales (Steven M)
6.08%
Rales (Mitchell P)
4.88%
BlackRock Institutional Trust Company, N.A.
4.10%
State Street Global Advisors (US)
3.83%
Other
72.81%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
8.31%
Rales (Steven M)
6.08%
Rales (Mitchell P)
4.88%
BlackRock Institutional Trust Company, N.A.
4.10%
State Street Global Advisors (US)
3.83%
Other
72.81%
Type
Shareholder
Proportion
Investment Advisor
38.05%
Investment Advisor/Hedge Fund
33.25%
Individual Investor
11.02%
Research Firm
2.49%
Hedge Fund
2.36%
Pension Fund
2.07%
Bank and Trust
2.03%
Sovereign Wealth Fund
1.38%
Family Office
0.38%
Other
6.95%
Institutional Shareholding
Update time: Sun, Jan 19
Update time: Sun, Jan 19
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
3816
667.12M
93.24%
-8.89M
2024Q4
3912
666.25M
93.21%
-12.81M
2024Q3
3803
666.72M
92.18%
-22.04M
2024Q2
3748
676.83M
91.56%
-20.35M
2024Q1
3757
684.50M
92.62%
-9.01M
2023Q4
3766
684.46M
92.71%
-1.58M
2023Q3
3680
678.81M
92.01%
-4.67M
2023Q2
3635
673.50M
91.35%
-658.33K
2023Q1
3602
668.24M
91.66%
-2.23M
2022Q4
3575
666.43M
91.51%
-6.25M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
59.47M
8.31%
+332.85K
+0.56%
Dec 31, 2024
Rales (Steven M)
43.49M
6.08%
+366.00
+0.00%
Mar 01, 2025
Rales (Mitchell P)
34.93M
4.88%
-202.39K
-0.58%
Mar 01, 2025
BlackRock Institutional Trust Company, N.A.
29.32M
4.1%
+350.54K
+1.21%
Dec 31, 2024
State Street Global Advisors (US)
27.38M
3.83%
-95.41K
-0.35%
Dec 31, 2024
Wellington Management Company, LLP
21.32M
2.98%
-1.99M
-8.53%
Dec 31, 2024
Fidelity Management & Research Company LLC
18.77M
2.62%
-3.07M
-14.05%
Dec 31, 2024
T. Rowe Price Associates, Inc.
18.05M
2.52%
-1.50M
-7.69%
Dec 31, 2024
Capital International Investors
17.66M
2.47%
-169.50K
-0.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
13.36M
1.87%
+315.45K
+2.42%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Parnassus Core Select ETF
6.37%
Macquarie Focused Large Growth ETF
3.65%
Monarch Blue Chips Core ETF
3.64%
God Bless America ETF
3.11%
Bancreek U.S. Large Cap ETF
3.1%
Goldman Sachs Future Health Care Equity ETF
2.52%
Proshares Ultra Health Care
2.46%
Health Care Select Sector SPDR Fund
2.42%
iShares U.S. Healthcare ETF
2.39%
VanEck Morningstar Wide Moat ETF
2.27%
View more
Parnassus Core Select ETF
Proportion6.37%
Macquarie Focused Large Growth ETF
Proportion3.65%
Monarch Blue Chips Core ETF
Proportion3.64%
God Bless America ETF
Proportion3.11%
Bancreek U.S. Large Cap ETF
Proportion3.1%
Goldman Sachs Future Health Care Equity ETF
Proportion2.52%
Proshares Ultra Health Care
Proportion2.46%
Health Care Select Sector SPDR Fund
Proportion2.42%
iShares U.S. Healthcare ETF
Proportion2.39%
VanEck Morningstar Wide Moat ETF
Proportion2.27%
Dividend
A total of
3.76B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 20, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Dec 10, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jan 31, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 31, 2025
Dec 27, 2024
Sep 10, 2024
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 25, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 25, 2024
Sep 27, 2024
May 07, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 21, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Apr 26, 2024
Mar 27, 2024
Dec 05, 2023
DHR.NB Interim Cash Dividend of gross USD 0.24 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Sep 13, 2023
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 27, 2023 going ex on Oct 11, 2023
Oct 12, 2023
Oct 27, 2023
Oct 11, 2023
May 09, 2023
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 28, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 28, 2023
Jun 29, 2023
Feb 22, 2023
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 06, 2022
DHR.NB Interim Cash Dividend of gross USD 0.25 paid on Jan 27, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 27, 2023
Dec 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data